Document:

Exhibit 10.24

 

CONSULTANT FEE AGREEMENT

 

 

 

THIS CONSULTANT FEE AGREEMENT (“Agreement”)
dated the 5th day of August, 2010.

 

Between:

 

VIRAL GENETICS INC.,

a Delaware incorporated company

(the “Company”)

 

-and-

 

PATTON CAPITAL CORP.

(the “Consultant”)

 

 

WHEREAS the Company wishes to appoint the Consultant
to introduce the Company to prospective Consultant Introductions (as defined below) on a non-exclusive basis as to one or more
Transactions (as defined below) and on an exclusive basis as to the Listing (as defined below), and the Consultant wishes to accept
such appointment;

 

NOW THEREFORE FOR GOOD AND VALUABLE CONSIDERATION,
the parties agree as follows:

 

1. Appointment and Acceptance

 

	1.1		The Company hereby appoints the Consultant to make
                                                                               Consultant Introductions for the purpose of securing a Transaction or Listing, and the Consultant hereby accepts such
                                                                               appointment (it being understood that, in acting as a consultant, the Consultant may introduce the Company to persons who may
                                                                               in turn introduce the Company to other persons (all such introductions, whether directly by Consultant or through entities
                                                                               introduced by Consultant, as well as Consultant itself and it's officers, directors and principal shareholders, are
                                                                               hereinafter referred to as “Consultant Introductions”)) in consideration of the compensation to which the
                                                                               Consultant is entitled under the terms of this Agreement. A "Listing" shall result where, through Consultant
                                                                               Introductions, the Company secures, acquires or merges with a NASDAQ listed company and/or obtains any other suitable listing
                                                                               on a recognized stock exchange, including the Toronto Stock Exchange, including a merger, reverse merger,reverse takeover
                                                                               and/or an acquisition transaction. A "Transaction" shall result where, through Consultant Introductions the Company
                                                                               secures or obtains any business development opportunity or cash funding, including, without limiting the generality of the
                                                                               foregoing,
license arrangements, research funding including government and non government grants, partnerships, joint
ventures, and public or private financings whether by way of debt or equity or a combination of both (two or more activities shall
be referred to as “Transactions”). A Listing resulting from a reverse takeover, reverse merger, acquisition or other
corporate reorganization or combination with a NASDAQ- or other recognized exchange-listed company, including the Toronto Stock
Exchange, holding cash, where, following closing, the shareholders of the Company before the Listing own more than 50% of the surviving
entity after closing, /or more than 50% of the board of directors of the surviving entity following closing were directors of the
Company before closing shall result in fees payable for a Transaction as defined in section 3.3. The acceptance and closing of
any part or all of any Transactions or Listing or combination thereof shall be at the sole discretion of the Company.

 

    	1

    	 

    

 

	1.2		The Company hereby acknowledges that the Consultant is not a registered broker, dealer
or an investment adviser within the meaning of the Canadian or United States securities laws or any provincial or state securities
laws.

 

2.Information

 

	2.1		The Company will furnish the Consultant with all required information of the Company
including a copy of the business plan prepared by the Company along with all ancillary required information (the “Business
Plan”) and in that connection will provide the Consultant reasonable and full access to the Company's officers, directors,
outside advisors, attorneys, auditors, accountants and other representatives or parties dealing with the Company. The Company
will be solely responsible for all such information including the contents of the Business Plan or other documents used in connection
with the consulting activities contemplated hereby. To the best of the Company's knowledge, after making all due inquiry and diligence,
all information to be furnished by the Company will be true and correct in all material respects. The Company agrees to the terms
of indemnification attached in Schedule A.

 

3.Compensation

 

	3.1		The Consultant shall be paid a fee of $8,000 on signing hereof and $8,000 on the 181
day of every month thereafter (“Monthly Fee”). The Monthly Fee is non-refundable and may be paid by way of shares or
cash as mutually agreed to by the parties. Where the payment is by way of shares, the price for each share shall be the lower
of $0.041 (the "Maximum Price") or the closing market price of the Company's common shares on the day that the Monthly
Fee is due, or if not a trading day then the following trading day. The Maximum Price shall subject to adjustment according to
section 3.5 below.

 

    	2

    	 

    

 

	3.2		In addition to the payments made by the Company to the Consultant in section 3.1 above,
upon the first and only the first closing (“Closing”) of all or part of any Transaction or the Listing, whether or not
the Company issues equity or equity equivalents, the Company will issue to the Consultant eleven million (11,000,000) warrants
to purchase shares of the Company (the “Warrants”) under the following terms and conditions. The exercise price of all
Warrants will be equal to the lower of the Maximum Price or the closing price of the Company's common shares on the date of the
Closing. The number of Warrants issuable shall be subject to adjustment according to section 3.5 herein. All Warrants to be issued
to the Consultant are exercisable for five (5) years from the date of issue and shall survive any reorganizations or restructurings,
and will be subject to registration rights that are equivalent to the most favourable rights then in place or granted subsequently
by the Company to other investors or shareholders for warrants or other stock options, as determined in the sole discretion of
the Consultant.

 

	3.3		In addition to the compensation contained in sections 3.1 and 3.2 above, where the
Company secures a Transaction, the Consultant shall be paid an amount equal to ten percent (10%) of the value of such Transaction
in cash plus an additional ten percent (10%) of the value of such Transaction in shares of the Company at a price equal to the
price per share for the funding or financing as the case may be, or, if no such price is available, then the then current market
price of the Company's common shares determined as the closing price on the date of the Closing.

 

	3.4		In addition, the Company shall be required to reimburse the Consultant for all out-of-pocket
expenses incurred and disbursements paid by the Consultant in the course of performing its duties under the terms of this Agreement;
provided, however, that the Consultant shall obtain the Company's prior written consent to such reimbursement over the amount
of one thousand dollars ($1,000.00), which consent shall not be unreasonably withheld.

 

	3.5		In the event that the Company shall undertake a recapitalization, reverse stock split,
forward stock split, reclassification, or other change to its common stock (a “Change in Common Stock Properties”),
the quantity of Warrants and the Maximum Price shall be increased or decreased proportionately, in accordance with the terms of
said Change in Common Stock Properties. ·

 

	3.6		In consideration of the Consultant providing its services to the Company under the
terms and conditions set forth in this Agreement, the parties hereto expressly agree that the Consultant shall be entitled to
compensation hereunder in connection with the activities provided for in this Agreement under sections 3.2 and 3.3 with respect
to all or part of a Transaction or Listing, financial or otherwise, entered into by the Company during
the term of this Agreement and for a period of twenty-four (24) months following termination of this Agreement and the Consultant
shall be remunerated accordingly as if this Agreement was still in full force and effect.

 

    	3

    	 

    

 

4.Term and Termination

 

	4.1		This Agreement shall have a Term of 12 months from the date affixed hereof, and may
be extended thereafter by mutual written consent. This Agreement may be terminated any time, however, with or without cause, by
either the Company or the Consultant. Termination of this Agreement shall not relieve the Company of its obligation to compensate
the Consultant pursuant to Section 3.6 of this Agreement. If this Agreement is terminated prior to the end of the initial 12-month
Term for any reason, the Monthly Fees shall continue to be due and payable to the Consultant for the initial 12-month Term. If
terminated at any time thereafter, only the Monthly Fees owed up to and including the date of termination shall be due and payable.

 

5.Securities Laws

 

The Consultant acknowledges that:

 

	5.1		No securities commission or similar regulatory authority has reviewed or passed on
the merits of the securities;

 

	5.2		There is no government or other insurance covering the securities;

 

	5.3		There are risks associated with the purchase of the securities; and

 

	5.4		The Company has advised the Consultant that the Company is relying on an exemption
from the requirements to provide a prospectus or any other form of disclosure documentation and to sell securities through a person
or company registered to sell securities under the Securities Act (Alberta) and, as a consequence of acquiring securities
pursuant to this exemption, certain protections, rights and remedies provided by the Securities Act (Alberta), including
statutory rights of rescission or damages, will not be available to the subscriber nor the Consultant.

 

	5.5		They are a Non-US Person.

 

6.Further Assurances

 

	6.1		The parties agree to take all necessary actions and execute such additional documentation
as may be necessary in order to implement this Agreement.

 

    	4

    	 

    

 

 

7.Amendments and Waivers

 

	7.1		Any term of this Agreement may be amended, waived or superseded only by mutual written
consent of the Company and/or its legal representatives and the Consultant or their respective permitted successors and assigns.
Any amendment or waiver effected in accordance with this Section shall be binding upon the parties and their respective permitted
successors and assigns.

 

8.Successors and Assigns

 

	8.1		Either party shall have the right to assign its rights, obligations and privileges
(by operation of law or otherwise) hereunder to an assignee that agrees in writing to be bound by the terms and conditions of
this Agreement with the consent of the other party, such consent not to be unreasonably withheld. Company hereby acknowledges
and consents to Consultant assigning any or all of the compensation due to Consultant hereunder provided that such assignment
is permitted under applicable securities laws. The terms and conditions of
the Agreement shall enure to the benefit of and be binding upon the respective permitted successors and assigns of the parties.
Nothing in the Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective
successors and assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly
provided in this Agreement.

 

9.Governing law

 

	9.1		The Agreement and all acts and transactions pursuant to this Agreement and the rights
and obligations of the parties hereto shall irrevocably be governed, construed and interpreted in accordance with the laws of
the Province of Alberta, without giving effect to principles of conflicts of law.

 

10.Jurisdiction

 

	10.1		Each of the parties to this Agreement irrevocably attorn to the exclusive jurisdiction
and venue of the provincial and federal courts of the Province of Alberta.

 

11.Titles and Subtitles

 

	11.1		The titles and subtitles used in this Agreement are used for convenience only and
are not to be considered in construing or interpreting this Agreement.

 

12.Notices

 

	12.1		Any notice required or permitted by this Agreement shall be in writing and shall be
deemed sufficient, when delivered by courier, overnight delivery service or confirmed facsimile, or forty-eight (4 hours after
being deposited in the regular mail as certified or registered mail (airmail if sent internationally) with postage prepaid, if
such notice is addressed to the party to be notified at such party's address or facsimile number as set forth below, or as subsequently
modified by written notice.

 

    	6

    	 

    

 

13. Severability

 

	13.1		If one or more provisions of this Agreement are held to be unenforceable under applicable
law, the parties agree to renegotiate such provision in good faith, in order to maintain the economic position enjoyed by each
party as close as possible to that under the provision rendered unenforceable.In the event that the parties cannot reach a
mutually agreeable and enforceable replacement for such provision, then (i) such provision shall be excluded from this Agreement,
(ii) the balance of this Agreement shall be interpreted as if such provision were so excluded and (iii) the balance of this Agreement
shall be enforceable in accordance with its terms.

 

14.Independent Contractor

 

	14.1		Neither party shall, for any purpose, be deemed to be an agent of the other party
and the relationship between the parties shall only be that of independent contractors. Neither party shall have any right or
authority to assume or create any obligations or to make any representations or warranties on behalf of any other party, whether
express or implied, or to bind the other party in any respect whatsoever (other than by the terms and provisions of this Agreement).

 

15.Confidentiality

 

	15.1		The Consultant agrees to keep confidential and not to disclose any information designated
as confidential by the Company to any third parties other than to a list approved by the Company of its officers, directors, employees,
representatives or agents. This confidentiality obligation shall survive termination of this agreement in perpetuity. This confidentiality
obligation shall not apply to Information for which the Consultant can demonstrate that such information (i) has been approved
for release by written authorization of the Company; (ii) is or becomes part of information in the public domain through no fault
of the Consultant; (iii) was known by the Consultant prior to the disclosure thereof by the Company; or (iv) properly comes into
the possession of the Consultant from a third party which is not under any obligation to maintain the confidentiality of such
information.

 

16.Entire Agreement

 

    	7

    	 

    

 

	16.1		This Agreement constitutes the entire agreement of the parties pertaining to the subject
matter hereof, and merges all prior negotiations and drafts of the parties with regard to the transactions contemplated herein.
Any and all other written or oral agreements existing between the parties hereto regarding such transactions are expressly cancelled.

 

17.Advice of Legal Counsel

 

	17.1		Each party acknowledges and represents that, in executing the Agreement, it has had
the opportunity to seek advice as to its legal rights from legal counsel and that the person signing on its behalf has read and
understood all of the terms and provisions of this Agreement. This Agreement shall not be construed against any party by reason
of the drafting or preparation thereof.

 

18.Arbitration

 

	18.1		Any controversy or claim arising out of or relating to this Agreement or the performance
or breach thereof shall be settled by arbitration in the, or such other venue as the parties agree, in accordance with the rules
and procedures of the Arbitration Act of Alberta. If more than one past or present agent or finder of the Company, including the
Consultant, claims to have introduced the same opportunity, the determination of the allocation of commissions will be settled
by arbitration.

 

19.Counterparts

 

	19.1		This Agreement may be signed in separate counterparts (including by telecopy), each
of which will be deemed an original and both of which together will constitute one and the same agreement.

 

    	8

    	 

    

 

 

 

    	9

    	 

    

 

Schedule
A: Indemnity

 

 

 

 

The Company
(the "Indemnifying Party''} hereby agrees to indemnify and hold the Consultant and each and every of the directors, officers,
employees, shareholders, agents and representatives of the Consultant (hereinafter referred to as the "Personnel") harmless
from and against any and all expenses, losses, claims, actions, obligations, damages or liabilities, whether joint or several (including
the aggregate amount paid in reasonable settlement of any actions, suits, proceedings or claims), and the reasonable fees and expenses
of its counsel that may be incurred in advising with respect to or defending any claim that may be made against the Consultant
or its Personnel to which the Consultant or its Personnel may become subject or otherwise involved in any capacity insofar as such
expenses, losses, claims, damages, liabilities or actions arise out of or are based, directly or indirectly, upon the engagement
of the Consultant hereunder or the performance of professional services rendered to the Indemnifying Party by the Consultant and
its Personnel hereunder or otherwise in connection with the matters referred to in the attached letter agreement, provided, however,
that this indemnity shall not apply to the extent that a court of competent jurisdiction in a final judgment that has become non-appealable
shall determine that:

 

i) the Consultant
or its Personnel have been grossly negligent or dishonest or have committed any fraudulent act in the course of such performance;
and

 

ii) the
expenses, losses, claims, actions, obligations, damages or liabilities, as to which indemnification is claimed, were directly caused
by the gross negligence, dishonesty or fraud referred to in (i).

 

If
for any reason (other than the occurrence of any of the events itemized in (i) and (ii)
above), the foregoing indemnification is unavailable to the Consultant or its Personnel or is insufficient
to hold it harmless, then the Indemnifying Party shall contribute to the amount paid or payable by the Consultant or its Personnel
as a result of such expense, loss, claim, actions, damage or liability in such proportion as is appropriate to reflect not only
the relative benefits received by the Indemnifying Party on the one hand and the Consultant on the other hand but also the relative
fault of the Indemnifying Party and the Consultant, as well as any relevant equitable considerations; provided that the Indemnifying
Party shall in any event contribute to the amount paid or payable by the Consultant as a result of such expense, loss, claim, actions,
damage or liability any excess of such amount over the amount of the fees received by the Consultant hereunder pursuant to this
Agreement.

 

The Indemnifying
Party agrees that in case any legal proceeding shall be brought against the Indemnifying Party, the Consultant or its Personnel
by any governmental commission or regulatory authority or any stock exchange or other entity having regulatory authority, either
domestic or foreign, shall investigate the Indemnifying Party or the Consultant and any Personnel of the Consultant shall be required
to testify in connection therewith or shall be required to respond to procedures designed to discover information regarding, in connection with, or by reason of the performance of professional services rendered
to the Indemnifying Party by the Consultant, the Consultant or its Personnel shall have the right to employ its own counsel in
connection therewith, and the reasonable fees and expenses of such counsel as well as the reasonable costs (including an amount
to reimburse the Consultant for time spent by its Personnel in connection therewith) and out-of-pocket expenses incurred by its
Personnel in connection therewith shall be paid by the Indemnifying Party as they occur.

 

Promptly after receipt of notice of the commencement
of any legal proceeding against the Consultant or any of its Personnel or after receipt of notice of the commencement of any investigation,
which is based, directly or indirectly, upon any matter in respect of which indemnification may be sought from the Indemnifying
Party, the Consultant will notify the Indemnifying Party in writing of the commencement thereof and, throughout the course thereof,
will provide copies of all relevant documentation to the Indemnifying Party, will keep the Indemnifying Party advised of the progress
thereof and will discuss with the Indemnifying Party all significant actions proposed.

 

The indemnity and contribution obligations of the Indemnifying Party shall be in addition to any liability
which the Indemnifying Party may otherwise have, shall extend upon the same terms and conditions to the Personnel of the Consultant
and shall be binding upon and enure to the benefit of any successors, assigns, heirs and personal representatives of the Indemnifying
Party, the Consultant and any of the Personnel of the Consultant. The foregoing provisions shall survive the completion of professional
services rendered under this Agreement or any termination of the authorization given by the Agreement.

 

 

	 	VIRAL GENETICS INC.
	 	 
	 	Per: /s/ Haig KeledjianExhibit 10.25

 

SUBSCRIPTION AGREEMENT

 

VIRAL GENETICS, INC.

2290 Huntington. Drive, Suite 100

San Marino, CA 91108

 

THE COMMON STOCK OF
VIRAL GENETICS, INC., INCLUDING THAT ACQUIRABLE UPON EXERCISE OF THE WARRANTS, DESCRIBED IN THIS SUBSCRIPTION AGREEMENT (this "Agreement")
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED ("Act"), OR QUALIFIED UNDER THE STATE SECURITIES
LAWS OF ANY STATE. THE SECURITIES ARE BEING SOLD IN RELIANCE ON EXEMPTIONS FROM SUCH REGISTRATION AND QUALIFICATION REQUIREMENTS.
THE SECURITIES AND .RIGHTS PURSUANT TO THIS AGREEMENT CANNOT BF SOLD, TRANSFERRED, ASSIGNED, OR OTHERWISE DISPOSED OF EXCEPT IN
COMPLIANCE WITH APPLICABLE FEDERAL AND STATE SECURITIES .LAWS, INCLUDING REGULATION S PROMULGATED UNDER THE ACT,

 

ALL OFFERS AND SALE
OF SAID SECURITIES BY NON-U.S. PERSONS PRIOR TO THE EXPIRATION OF A PERIOD COMMENCING ON THE DATE OF THE CLOSING OF THIS OFFERING
AND ENDING ONE-YEAR THEREAFTER SHALL ONLY BE MADE IN COMPLIANCE WITH THE SAFE HARBOR CONTAINED IN REGULATION S, PURSUANT TO THE
REGISTRATION PROVISIONS UNDER THE SECURITIES ACT OF 1933, OR PURSUANT TO AN EXEMPTION FROM REGISTRATION, AND ALL OFFERS AND SALES
AFTER THE EXPIRATION OF THE ONE-YEAR PERIOD SHALL BE MADE ONLY PURSUANT TO REGISTRATION OR AN EXEMPTION FROM REGISTRATION,

 

This Agreement shall
constitute the irrevocable offer of the undersigned to purchase, in the amounts and subject to the terms set forth in this Agreement,
up to 4,000,000 Units at a purchase price of $0,02 per Unit (Undersigned to insert number of Units 'purchased on page 5). Each
Unit is comprised of one share of the Common Stock of Viral Genetics, Inc., a Delaware corporation (the "Company") ("Shares"),
and one warrant, each of which allows the holder to acquire one Share, in the form attached hereto as Exhibit A (the "WarrantS"),
(the Shares and the Warrants referred to herein as the "Securities."). On execution by both parties, this
Agreement shall become a bilateral agreement binding on both the undersigned and the Company, Each part of this Agreement must
be completed by the undersigned and, by execution below, the undersigned acknowledges that it understands that • the Company
is relying on the accuracy and completeness hereof in complying with its obligations under applicable securities laws.

 

On the foregoing, it is hereby agreed as follows:

 

1.SUBSCRIPTION The undersigned hereby
irrevocably subscribes for the purchase of the Securities. The undersigned is tendering to the Company:

 

		(a)	one signed copy of this Agreement; and

		(b)	payment in the amount of $0.02 per Unit up to a maximum of $80,000 (the "Purchase Price").

 

2.GENERAL REPRESENTATIONS
OF SUBSCRIBER. The undersigned hereby represents and warrants as follows:

    	1

    	 

    

 

(a)The undersigned is over the age of 18 years;

 

(b)The
undersigned acknowledges that neither the United States Securities and Exchange Commission nor the securities commission of any
state or other federal agency has made any determination as to the merits of purchasing these securities;

 

(c)The
undersigned has received and read all of the Company's filings made on the OTCIQ News and Disclosure system and available at www.pinksheets.com
including the "Quarterly Report" and "Consolidated Financial Statements" for the three months ended
March 31, 2010; the "Annual Report" and "Consolidated Financial Statements" for the fiscal year ended December
31, 2009 filed on April 15, 2010 and provided along with this agreement; the "Initial Company Information and Disclosure
Statements" for the nine months and three months ending September 30, 2009 and March 31, 2009, respectively; the "Articles
of Incorporation — Amendment" filed May 15, 2009; and the "Supplemental. Information — Current Reporting
Obligations Filing — Merger” filed April 24, 2009; as well as all prior filings made on the SEC EDGAR system including, without
limitation, the Form 10-KSB, as amended, for the fiscal year ended December 31, 2006, the Quarterly Report on Form 10-QSB for
the quarter ended September 30, 2007, all Current Reports on Form 8-K, all other filings and disclosures made on the OTC1Q News
and Disclosure system and available at www.pinksheets.com, all press releases, and other information.; and the undersigned
understands the risk of an investment in the Company, acknowledging that an investment in the Company inherently involves high
risks.

 

(d)The
undersigned, either alone or with the assistance of one or more advisers engaged by it, has such knowledge and experience in business
and financial matters that it or they is capable of evaluating the Company, its business operations, and the risks and merits of
an investment in the Company;

 

(e)The
undersigned has been provided with all materials and information requested by the undersigned or its representatives, including
any information requested to verify any information furnished, and the undersigned has been provided the opportunity for direct
communication between the Company and its representatives and the undersigned and its representatives regarding the purchase made
hereby, including the opportunity to ask questions of and receive answers from the Company including with regards to any of the
information described in 2 (c) above;

 

(f)All information which the undersigned has
provided to the Company or its agents or representatives concerning the undersigned's suitability to invest in the Company is
complete, accurate, and correct as of the date of the undersigned's signature on this Agreement. Such information includes, but
is riot limited to, information concerning the undersigned's personal financial affairs, business position, and the knowledge
and experience of the undersigned and the undersigned's advisers;

 

(g).The
undersigned has no present intention of dividing any of the securities or the rights under this Agreement with others or
of reselling or otherwise disposing of any portion of the securities, either currently or after the passage of a. fixed or determinable
period of time or on the occurrence or nonoccurrence of any predetermined event or circumstance;

 

(h)The
undersigned was at no time solicited by any leaflet, public promotional meeting, circular, newspaper or magazine article, radio
or television advertisement, or any other form of general advertising or solicitation in connection with the offer, sale, or purchase
of the securities through this Agreement; and

 

(i)The
undersigned has adequate means of providing for its current needs and possible contingencies and has no need now and
anticipates no need in the foreseeable future, to sell any portion of the securities for which the undersigned hereby
subscribes. The undersigned is able to bear the economic risks of this investment and,
consequently, without limiting the generality of the foregoing, is able to hold the securities for an indefinite period of
time, and has a sufficient net worth to sustain a loss of the entire investment, in the event such loss should
occur.

 

    	2

    	 

    

 

(j)The undersigned is an Accredited investor, and has completed the following Accredited Investor Qualifying Questionnaire:

 

PERSONAL FINANCIAL INFORMATION,
The following information pertaining to the undersigned as a natural person and U.S. Persons within the
meaning of Regulation S is being provided here in lieu of furnishing a personal financial statement.

 

(a)My
individual net worth, or joint net worth with my spouse, exceeds $1,000,000.

 

Yes [x]No[ ]

 

(b)My
individual income in 2008 and 2009 exceeded $200,000 in each such year, and I reasonably expect my individual income will be
in excess of $200,000 in 2010.

 

Yes [ ]No [ ]

______

INITIAL

 

(c)The
joint income of my spouse and I in 2008 and 2009 exceeded $300,000 in each such year, and I reasonably expect our joint income will be in excess of $300,000 in 2010.

 

Yes [ ]No [ ]

______

INITIAL

 

(d)Considering
the foregoing and all other relevant factors in my financial and personal circumstances, I am able to bear the economic risk of an investment in the Company.

 

Yes [ ]No [ ]

 

______

INITIAL

 

3.REPRESENTATIONS
REGARDING EXEMPTIONS AND. RESTRICTIONS ON TRANSFER. The
undersigned represents that the securities are being acquired without a view to, or for, resale in connection with any distribution
of the securities or any interest therein without registration or other compliance under the Act, and that the Undersigned has
no direct or indirect participation in any such undertaking or in the underwriting of such an undertaking. The undersigned understands
that the securities have not been registered, but are being acquired by reason of a specific exemption under the Act as well as
under certain state statutes for transactions by an issuer not involving any public offering and that any disposition of the securities
may, under certain. Circumstances, be inconsistent with this exemption and may make the undersigned an "underwrite”
within the meaning of the Act. The undersigned acknowledges that the securities must be held and may not be sold, transferred,
or otherwise disposed of for value unless they are subsequently registered under the Act or an exemption from such registration
is available. The Company is under no obligation to register the securities under the Act or under Section 12 of the Securities
Exchange Act of 1934, as amended, except as may be expressly agreed to by it in writing. The certificates representing the securities
will bear a legend restricting transfer, except in compliance with applicable federal and state securities statutes.

 

    	3

    	 

    

 

4.
GENERAL. The undersigned further understands, acknowledges, and agrees that:

 

(a)This
Agreement is registered in the name of the undersigned on the books of the Company at its principal offices, and no transfer hereof
shall be valid and binding on the Company unless made at such offices by the registered holder or his attorney-in-fact duly authorized
in writing. The Company may deem and treat the person in whose name this Agreement is registered as the absolute owner hereof for
the purpose of receiving any securities issuable pursuant hereto and for all other purposes.

 

(b)This
Agreement shall be construed in accordance with and governed by the laws of the state of California.

 

(c)This
Agreement constitutes the entire agreement between the parties respecting the subject matter hereof.

 

(d)Notwithstanding
any of the representations, warranties, acknowledgments, or agreements made herein by the undersigned, the undersigned does not
waive any rights granted to the undersigned under federal and state securities laws.

 

(e)The undersigned will hold title to the securities as follows:

 

_____Community Property

 

_____Joint Tenants, with Right
of Survivorship

 

_____Tenants in Common

 

_____Separate Property

 

    X    Other
Single person                                         

(Single Person,
Trust,Etc., Please Indicate)

 

    	4

    	 

    

 

DATED this 17TH       
day of      August                   2010.

 

	UNITS
    PURCHASED:	500,000

 

 

	 	 	Sheila Williams
	Tax Identification Number or Social Security Number	 	Type or Print Name of Subscriber(s) in
    exact Form to be Used on Records of the
Company
	 	 	 
	Address:	 	 
	 	 	 
	[xxx]	 	/s/ Sheila Williams
	Number and Street	 	 
	 	 	 
	[xxx]	 	 
	City, State, and Postal Code	 	Signature of Joint
Subscriber, If Any
	 	 	 
	USA	 	Date: 8/17/10
	Country	 	 

 

 

ACCEPTANCE OF SUBSCRIPTION

 

The foregoing is hereby accepted this 
17th  day of    August        
2010.

 

VIRAL GENETICS, INC:

 

 

By /s/ signature                                               

Duly Authorized Officer

 

 

    	5

    	 

    

 

VIRAL GENETICS, INC.

Warrant for the Purchase
of

Shares of Common Stock

Par Value 50.8001

 

WARRANT AGREEMENT

 

THE
HOLDER OF THIS WARRANT, BY ACCEPTANCE HEREOF, BOTH WITH RESPECT TO THE WARRANT AND COMMON STOCK ISSUABLE UPON EXERCISE OF THE
WARRANT, AGREES AND ACKNOWLEDGES THAT THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR UNDER THE SECURITIES LAWS OF ANY STATE. THESE
SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE TRANSFERRED OR SOLD IN THE ABSENCE OF AN EFFECTIVE REGISTRATION
STATEMENT OR OTHER COMPLIANCE UNDER THE SECURITIES ACT OR THE LAWS OF THE APPLICABLE STATE OR A "NO ACTION" OR
INTERPRETIVE LETTER FROM THE SECURITIES AND EXCHANGE COMMISSION OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE
ISSUER, AND ITS COUNSEL, TO THE EFFECT THAT THE SALE OR TRANSFER IS EXEMPT FROM REGISTRATION UNDER THE SECURITIES ACT AND
SUCH STATE STATUTES.

 

This
is to certify that, for value received, Rodney Williams (the "Holder") is entitled to purchase From VIRAL GENETICS,
INC., a Delaware corporation (the "Company"), on the terms and conditions hereinafter set forth, all or any part
of  500,000  shares ("Warrant Shares") of the Company's common stock, par value $0.0001 (the "Common Stock"),
at the purchase price of $0.03 per share ("Warrant Price"). Upon exercise of this warrant in whole or in part, a certificate
for the Warrant Shares so purchased shall be issued and delivered to the Holder. If less than the total warrant is exercised,
a new warrant of similar tenor shall be issued for the unexercised portion of this warrant By acceptance hereof, the Holder agrees
to be bound by the terms and conditions of this warrant.

 

This warrant is granted subject to the following further
terms and conditions:

 

1. This
warrant shall vest and be exercisable immediately, and Shall expire at 5:00 pm Pacific Time on the two-year anniversary of
the date affixed hereof In order to exercise this warrant with respect to all or any part of the Warrant Shares for which
this warrant is at the time exercisable, Holder must take the following actions:

 

		(a)	Deliver to the Corporate Secretary of the Corporation an executed notice
of exercise in substantially the form of notice attached to this Agreement (the "Exercise Notice") in which there is specified the number
of Warrant Shares that are to be purchased under the exercised warrant,

 

		(b)	Pay the aggregate Warrant Price for the purchased shares through full payment
in cash or by check made payable to the Corporation's order.

 

		(c)	Furnish to the Corporation appropriate documentation that the person or
                                                                                                  persons exercising the warrant (if other than Holder) have the right to exercise this warrant.

 

		(d)	For purposes of this Agreement, the Exercise Date shall be the date on which
the executed Exercise Notice shall have been delivered to the Company. Except to the extent the sale and remittance procedure specified
above is utilized in connection with the warrant exercise,
payment of the Warrant Price for the purchased shares must accompany such Exercise Notice.

 

    	6

    	 

    

 

	 	(e)	Upon such exercise, the Company
shall issue and cause to be delivered with all reasonable dispatch (and in any event within three business days of such exercise)
to or upon the written order of the Holder at its address, and in the name of the Holder, a certificate or certificates for the
number of full Warrant Shares issuable upon the exercise together with such other property (including cash) and securities as may
then be deliverable upon such exercise. Such certificate or certificates shall be deemed to have been issued and the Holder shall
be deemed to have become a holder of record of such Warrant Shares as of the. Exercise Date.

 

2.The
Warrant Shares have not and may not be registered as of the date of exercise of this warrant under the Securities Act or the securities laws of any state. This warrant and the Warrant Shares issuable on exercise
of the warrant, when and if issued,: are and may be "restricted securities" as defined in Rule 144 promulgated by the
Securities and Exchange Commission and must be held indefinitely unless subsequently registered under the Securities Act and any
other applicable state registration requirements, or an exemption from such registration requirements for resale is available,
The Company is under no obligation to register the securities under the Securities Act or under applicable state statutes. In the
absence of such a registration or an available exemption from registration, sale of the Warrant Shares will be prohibited. The
Holder shall confirm to the Company the representations set forth above in connection with the exercise of all or any portion of
this warrant.

 

3.The
Company, during the term of this Agreement, will obtain from the appropriate regulatory agencies any requisite authorization in order to issue and sell such number of shares of its Common Stock as shall be
sufficient to satisfy the requirements of the Agreement.

 

4.The
number of Warrant Shares purchasable upon the exercise of this warrant and the Warrant Price per share shall be subject to adjustment from time to time subject to the following terms. if the outstanding shares
of Common Stock of the Company are increased, decreased, changed into or exchanged for a different number or kind of shares of
the Company through reorganization, recapitalization, reclassification, stock dividend, stock split or reverse stock split, the.
Company or its successors and assigns shall make an appropriate and proportionate adjustment in the number or kind of shares, and
the per-share Warrant Price thereof; which may be issued to the Holder under this Agreement upon exercise of the warrants granted
under this Agreement. The purchase rights represented by this warrant shall not be exercisable with respect to a fraction of a
share of Common Stock. Any fractional shares of Common Stock arising from the dilution or other adjustment in the number of shares
subject to this warrant shall be rounded up to the nearest whole share.

 

5,The Company covenants
and agrees that all Warrant Shares Which may be delivered upon the exercise of this warrant will, upon delivery, be free from
all taxes, hens, and charges with respect to the purchase thereof; provided, that the Company shall have no obligation with respect
to any income tax liability of the Holder.

 

6.The Company agrees at all times to reserve
or hold available a sufficient number of shares of Common Stock to cover the number of Warrant Shares issuable upon the exercise
of this and all other warrants of like tenor and other convertible securities then outstanding,

 

7.This
warrant shall not entitle the Holder hereof to any voting rights or other rights as a shareholder
of the Company, or to any other rights whatsoever, except the rights herein expressed, and no dividends shall be payable or
accrue in respect of this warrant or the interest represented hereby or the Warrant Shares purchasable hereunder until or
unless, and except to the extent that, this warrant shall be exercised.

 

    	7

    	 

    

 

8.The
Company may deem and treat the registered owner of this warrant as the absolute owner hereof for all purposes and shall not be affected by any notice to the contrary.

 

9.In
the event that any provision of this Agreement is found to be invalid, or otherwise unenforceable under any applicable law, such invalidity or unenforceability shall not be construed as rendering any other provisions
contained herein invalid or unenforceable, and all such other provisions shall be given full force and effect to the same extent
as though the invalid or unenforceable provision were not contained herein.

 

10.This
Agreement shall be governed by and construed in accordance with the internal laws of the state of Delaware, without regard to the principles of conflicts of law thereof

 

11.In
case this warrant shall be mutilated, lost, stolen, or destroyed, the Company may at its discretion issue and deliver in exchange and substitution for and on cancellation of the mutilated warrant, or in lieu of and substitution
for the warrant lost, stolen, or destroyed, a new warrant of like tenor and representing an equivalent right or interest; but only
on receipt of evidence satisfactory to the Company of such loss, theft, or destruction of this warrant and indemnity satisfactory
to the Company. The Holder shall also comply with such other reasonable regulations and pay such other reasonable charges as the
Company may prescribe.

 

12.This
Agreement shall be binding on and inure to the benefit of the Company and the person to whom a warrant is granted hereunder, and such person's heirs, executors, administrators, legatees, personal representatives,
assignees, and transferees.

 

IN WITNESS WHEREOF,
the Company has caused this warrant to be executed by the signature of its duly authorized officer, effective this 17th day
of August, 2010

VIRAL GENETICS, INC.

 

BY     /s/ signature                                         

Duly Authorized Officer

 

 

 

 

 

Certain portions of the exhibit, indicated by the mark
“[***],” redacted pursuant to a confidential treatment order

    	8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00232-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00232-of-00352.parquet"}]]